 who have >50% carotid stenosis and have developed symptoms of TIA or stroke
were found to benefit from CEA in the pivotal North American Symptomatic Carotid
Endarterectomy Trial (NASCET) because of the significant 2-year stroke risk reduction
as compared to optimal medical management (15.7% vs. 22.2%.). An even greater stroke
risk reduction was seen in patients with >70% carot